drugset / Trial / NCT00705757

The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye

NCT00705757

Phase 4 Completed 89 enrolled Summa Health System
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to study changes in skin color that may be caused by using one of the three eye medicines: Xalatan, Travatan or Lumigan.

Timeline

Start
2008-03
Primary completion
2011-04
Completion
2011-04

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bimatoprost Other / unclassified 0.03 % Other
Comparator Latanoprost Small molecule 0.005 % Other
Comparator Travoprost Other / unclassified 0.004 % Other